Form D · Venture Capital Fund

PETRICHOR SCION THERAPEUTICS LLC

New York, NY · CIK 0001893188

Offering snapshot reported Mar 15, 2023 · SEC filing

Reported sold
$172M
Indefinite offering
Investors reported
49
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Jan 21, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported investors0 → 49

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 15, 2023Amendment$172,250,000No comparison49SEC filing
Jan 20, 2022InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-430236

Source: Form D, filed Mar 15, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.

Matched by reported Form D file number

SCION LIFE SCIENCES I, LLC

Investment adviser: PETRICHOR HEALTHCARE CAPITAL MANAGEMENT LP

Gross asset value
$296M
Beneficial owners
100
ADV minimum commitment
$5M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SEI GLOBAL SERVICES, INC OAKS, Pennsylvania, United States Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →
Auditor BDO USA, P.C. NEW YORK, New York, United States Other funds reporting this name →
Custodian CITIZENS BANK NA PROVIDENCE, Rhode Island, United States Related to adviser: No Other funds reporting this name →
Custodian CITY NATIONAL BANK NEW YORK, New York, United States Related to adviser: No Other funds reporting this name →
Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No Other funds reporting this name →
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

BDO USA, P.C.
PCAOB 243

CITIZENS BANK NA
LEI DRMSV1Q0EKMEXLAU1P80

CITY NATIONAL BANK
LEI 593C3GZG957YOJPS2Z63

JPMORGAN CHASE BANK, N.A.
LEI 7H6GLXDRUGQFU57RNE97

Fund asset history · 5 annual observations Gross asset value by annual ADV filing$0$148M$297MFY 2021: $106,950,000.00FY 2021FY 2022: $148,436,139.00FY 2022FY 2023: $280,766,064.00FY 2023FY 2024: $296,647,130.00FY 2024FY 2025: $296,221,407.00FY 2025

Scroll to see all columns →

Fiscal yearGross assetsBeneficial ownersADV filed
2021$106,950,00037Mar 31, 2022
2022$148,436,13945Mar 30, 2023
2023$280,766,06480Mar 29, 2024
2024$296,647,13099Mar 28, 2025
2025$296,221,407100Mar 31, 2026
Filing source

Form ADV 2069499 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-2214412866

Reported by PETRICHOR HEALTHCARE CAPITAL MANAGEMENT LP (CRD 288664).

Annual Updating Amendment for Registered Adviser · fiscal year 2025.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Samuel W. Hall Executive, Promoter
Aaron Kantoff Executive, Promoter
Tadd Wessel Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
220 E 42 Nd St
New York, NY, 10017
Phone: 917-513-7588